Loading
Latest filing published 20 Dec 2023 for ImmunoPrecise Antibodies Ltd..
No signal scores available.
Mitchell Levine discloses dealings in ImmunoPrecise Antibodies Ltd. to SEDI. The record holds 2 filings, for trades running from 9 November 2023 to 18 December 2023.
No open-market sale appears; the market trades are 1 purchase worth €9,488. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The record was last updated on 20 December 2023 with a transaction in ImmunoPrecise Antibodies Ltd. The last purchase on record was published on 20 December 2023, which is 1,040 days ago. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations